Renal Cancer - Results from #240

Beyond the Abstract - Metastatic renal cell carcinoma to the phalanx, by Douglas F. Beach, MD and Robert Somer, MD July 31, 2012

Beyond the Abstract - Validation of the 2009 TNM classification for renal cell carcinoma: Comparison with the 2002 TNM classification by concordance index, by Dalsan You, MD, PhD; Chunwoo Lee, MD; and Choung-Soo Kim, MD, PhD July 13, 2012

Beyond the Abstract - Utility of the R.E.N.A.L. nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass, by Daniel Canter, Alexander Kutikov, and Robert G. Uzzo June 29, 2012

Beyond the Abstract - Surgical management of large renal tumors, by Srinivas Vourganti, Brian Shuch, and Gennady Bratslavsky June 27, 2012

Beyond the Abstract - Role of sorafenib in renal cell carcinoma: Focus on elderly patients, by Giuseppe Procopio, MD April 13, 2012

Beyond the Abstract - Simultaneous laparoendoscopic single-site radical nephrectomy for native kidney and open nonischemic partial nephrectomy to treat concomitant renal cell carcinomas in native and transplant kidneys and to preserve allograft function April 11, 2012

Beyond the Abstract - Atypical presentations and rare metastatic sites of renal cell carcinoma: A review of case reports, by Petros Sountoulides, MD, PhD, FEBU and Luca Cindolo, MD, FEBU January 30, 2012

Beyond the Abstract - Persistent overuse of radical nephrectomy in the elderly, by Max Kates and James M. McKiernan, MD January 23, 2012

Beyond the Abstract - Metastatic renal cell carcinoma: Relationship between initial metastasis hypoxia, change after 1 month's sunitinib, and therapeutic response: An 18F-fluoromisonidazole PET/CT study, by Florent Hugonnet January 20, 2012

Beyond the Abstract - mRNA expression of bone morphogenetic proteins and their receptors in human renal cell carcinoma, by Dean Markić, MD, PhD, FEBU January 10, 2012

Beyond the Abstract - Morbidity of tumour enucleation for renal cell carcinoma (RCC): Results of a single-centre prospective study, by Gianni Vittori, Andrea Minervini, and Marco Carini December 13, 2011

Beyond the Abstract - Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: Recommendations from a European nursing task group, by Kim Edmonds, RN., November 29, 2011

Beyond the Abstract - Everolimus for the treatment of advanced renal cell carcinoma, by Robert J. Amato, DO and Mika Stepankiw, MS October 26, 2011

Beyond the Abstract - Management of metastatic renal cell carcinoma in the era of targeted therapies, by Kate Webber, BSc (Med), MBBS, FRACP, et al October 18, 2011

Beyond the Abstract - Putative biomarker genes for grading clear cell renal cell carcinoma, by Matthias Maruschke, MD, et al October 12, 2011

Beyond the Abstract - Present and future therapeutic options for locally advanced and metastatic renal cell carcinoma, by Sfoungaristos Stavros, MD, et al July 6, 2011

AUA 2011 - Characteristics of small renal masses progressing to metastases while under observation: A pooled analysis - Beyond the Abstract June 5, 2011

AUA 2011 - Has a minimally invasive approach become more important than nephron preservation in the management of the clinically localized renal mass? - Beyond the Abstract June 3, 2011

Beyond the Abstract - Overall survival and updated results from a phase II study of sunitinib in Japanese patients with metastatic renal cell carcinoma, by Hideyuki Akaza, MD May 9, 2011

Beyond the Abstract - Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients, by A. Goh and A. Vathsala March 16, 2011

Page 13 of 14

email news signup